Experimental Basis of Bone Marrow Purging with Chemical and Photodynamic Agents
The major stumbling-block in ABMT is the high relapse rate compared to that observed in both allogeneic and syngeneic marrow transplant (1). This is possibly due to occult leukemic cells contaminating the remission marrow. Although the efficacy of the ex-vivo purging procedure has yet to be definitely established in clinical practice, there are indications that cleansing the marrow is associated with improved survival in some cases (1, 2). To meet the obvious need for methods capable of eliminating these cells from autologous marrow, several techniques have been investigated (3–7).
KeywordsPluripotential Stem Cell Autologous Bone Marrow Transplantation Clonogenic Cell Acute Myelogenous Leukemic Cell Limit Dilution Assay
Unable to display preview. Download preview PDF.
- 1.Gorin NC, Aegerter P (1987) Autologous bone marrow transplantation for acute leukemia in remission: 4th EBMT survey. Bone Marrow Transplantation 2 (suppl. 1):320–21Google Scholar
- 2.Yeager AM, Kaizer H, Santos GW, Sarai R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH, Fuller DJ, Davis JM, Karp JE, Stradford May W, Rowley SD, Sensenbrenner LL, Vogelsang GB, Wingard JR (1986) Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Eng J Med 315:141–47CrossRefGoogle Scholar
- 5.Uckun FM, Ramakrishnan S, Houston LL (1985) Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell- specific immunotoxin containing pokeweed antiviral protein. Canc Res 45:69–75Google Scholar
- 7.Uckun FM, Gajl-Peczalska K, Meyers DE, Ramsay NC, Kersey JH, Colvin M, Vallera DA (1987) Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: Efficacy of ex-vivo treatment with immunotoxins and 4- hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells. Blood 69:361–65PubMedGoogle Scholar
- 9.Sarpel SC, Epstein RB (1979) Chemoseparation of cell populations in dogs by activated cyclophosphamide. Blood 54:230a (abstr.)Google Scholar
- 14.Porcellini A, Talevi N, Marchetti-Rossi MT, Manna A, Sparaventi G, Palazzi M (1985) Selective elimination of leukemic cells from marrow cell suspensions by mafosfamide (AZ) or merocyanine-540 (MC). Blood 66(suppl. 1): 270 (abstr.)Google Scholar